P2Y12 inhibitors for the neurointerventionalist
| Autor: | David Fiorella, Hegoda Ld Makalanda, Charlotte R Hickman, Maurizio Fuschi, Leonard L.L. Yeo, Pervinder Bhogal, Ken Wong, Robin J Borchert, Benjamin Yong-Qiang Tan, Davide Simonato, Hans Henkes, Lucie Thibault |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry Endovascular Procedures medicine.disease Mechanical thrombectomy Clinical Practice Route of administration P2Y12 Aneurysm Hemorrhagic complication medicine Humans Stents cardiovascular diseases Onset of action Intensive care medicine business Stroke Platelet Aggregation Inhibitors |
| Zdroj: | Interventional Neuroradiology. 28:92-103 |
| ISSN: | 2385-2011 1591-0199 |
| Popis: | The use of antiplatelets is widespread in clinical practice. However, for neurointerventional procedures, protocols for antiplatelet use are scarce and practice varies between individuals and institutions. This is further complicated by the quantity of antiplatelet agents which differ in route of administration, dosage, onset of action, efficacy and ischemic and hemorrhagic complications. Clarifying the individual characteristics for each antiplatelet agent, and their associated risks, will increasingly become relevant as the practice of mechanical thrombectomy, stenting, coiling and flow diversion procedures grows. The aim of this review is to summarize the existing literature for the use of P2Y12 inhibitors in neurointerventional procedures, examine the quality of the evidence, and highlight areas in need of further research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|